Sep 14, 2026 | Drug costs, MedBen Rx, Pharmacy, Prescription, Rebates, Rx Costs
A large rebate can look like a bargain, but often it only offsets a higher list price. Manufacturer rebates are typically a percentage of list price, so raising the list price makes the rebate look bigger without reducing what the plan pays. That is why rebate size is...
Aug 3, 2026 | Biosimilars, Cost Savings, Drug costs, Pharmacy, Prescription, Rx Costs, Savings, Specialty Drugs
Specialty drug costs are projected to jump another 32% by 2028, according to the Pharmacy Strategies Group. While greater utilization remains the primary driver, lower-cost biosimilars can help pharmacy plans offset the increase. Biosimilars’ overall market share...
Jul 16, 2026 | MedBen Rx, Member Prescription Portal, Mobile App, Online Services, Pharmacy, Prescription, Prescription Portal
Nearly one-third of middle-aged Americans struggle with common health tasks, including remembering doctor instructions and properly following medication directions, according to new research. Simple details — when to take a medication, whether to take it with food, or...
Jun 5, 2026 | Announcements, Compliance, Consolidated Appropriations Act of 2021 (CAA), Pharmacy, Regulatory
As you may recall, the Consolidated Appropriations Act of 2021 (CAA) requires all health plans to file a pharmacy data report annually with the Centers for Medicare & Medicaid Services (CMS). For the 2025 reporting cycle, the Prescription Drug Data Collection...
Apr 20, 2026 | Alternative Reimbursement Strategies, Client Report, Compliance, MedBen Access, MedBen Employees, MedBen News, MedBen University, Pharmacy, Regulatory, Spending, Wellness
MedBen had a full house of employers and brokers in attendance at MedBen University’s (MBU) 25th annual Employer Roundtable on April 16 at the C. Arthur Morrow Conference Center in Newark, Ohio. Presented by MedBen’s team of industry experts, this year’s roundtable...
Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
